ArticleTransplantation and cellular therapy2023

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.

Bronwen E Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.